Category:
Active Pharmaceutical Ingredients
CAS NO:
944396-07-0
Standard:
In-house Standards,
Oncology Breast Cancer
Buparlisib (BKM120) is a potent, oral pan-PI3K inhibitor developed for oncology. Its core synthesis involves advanced heterocyclic coupling. Molecular Formula: C24H26F3N5O; CAS No.: 879157-49-4.
Strictly for research use only; not approved for clinical therapy. Store under inert atmosphere at -20°C. Handle with appropriate PPE due to potential toxicity and mutagenicity risks.